The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Statins: mechanism of action and effects
Open accessAbstract
The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the Statin class of drugs inhibit 3-hydroxy-3-methylglutaryl (HMG) CoA reductase (HMGCR), the rate-limiting enzyme of de novo cholesterol synthesis5”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Statins (3-Hydroxy-3-methylglutaryl CoA reductase inhibitors) inhibit the endogenous synthesis of cholesterol by inhibiting the rate-limiting enzyme of the mevalonate pathway.(14)”
From Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis (2025) · cites this paper as [14]
In the citing paper
“Statins are competitive inhibitors of HMG-CoA reductase, which catalyses the conversion of HMG-CoA to mevalonate, a rate-limiting step in the isoprenoid biosynthetic pathway, which is involved in the synthesis of cholesterol in humans and ergosterol in fungi [10] .”
From Statins as antifungal agents (2011) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Research works printed but not linked: 2
- Voet D., 1995, Biochemistry, 315
- StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).
Cited by
Sorted by citations
Items 401–500 of 910
Alhawari, H. H., Jarrar, Y. B., AlKhatib, M. A., Alhawari, H. H., Momani, M. S., Zayed, A. A., Alkamhawi, R., & Zihlif, M. A. (2020) · Life · doi:10.3390/life10100232 · Cited by 12
Aichholzer, M., Gangadin, S. S., Sommer, I. E., Wijkhuijs, A. J. M., de Witte, L. D., Kahn, R. S., Bahn, S., Drexhage, H. A., & Schiweck, C. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100551 · Cited by 11
THE ROLE OF NITRIC OXIDE (NO) AND STATINS IN ENDOTHELIAL DYSFUNCTION AND ATHEROSCLEROSIS
Suciu, M. (2009) · Cited by 12
Li, H., Wang, C., Zhang, S., Sun, S., Li, R., Zou, M., & Cheng, G. (2016) · Drug Safety · doi:10.1007/s40264-016-0394-0 · Cited by 12
Effect of statins on SARS-CoV-2 infectionPreprint
Moeller, R. A., Belinchón, F. J. Z., Laßwitz, L., Kirui, J., Brogden, G., Gunesch, A. P., Pietschmann, T., Wichmann, D., Kluge, S., & Gerold, G. (2020) · medRxiv · doi:10.1101/2020.07.13.20152272 · Cited by 12
Aldworth, H., & Hooper, N. M. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230918 · Cited by 11
Prostate Cancer and the Mevalonate Pathway
Guerrero‐Ochoa, P., Rodríguez-Zapater, S., Anel, A., Esteban, L. M., Camón-Fernández, A., Espílez, R., Gil‐Sanz, M. J., & Borque‐Fernando, Á. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042152 · Cited by 14
Ashrafi, M., Karimí, B., Sabahi, M., & Shomali, T. (2018) · Biomedical Research and Therapy · doi:10.15419/bmrat.v5i3.421 · Cited by 11
Ansari, J. M., Ramhormozi, P., Shabani, R., Pazoki–Toroudi, H., Yari, A., Barati, M., Dahmardehei, M., Babakhani, A., & Nobakht, M. (2020) · PubMed Central · doi:10.22038/ijbms.2020.39782.9465 · Cited by 11
Dudhipala, N., Ettireddy, S., & Puchakayala, G. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105081 · Cited by 11
Perioperative Statin Use May Reduce Postoperative Arrhythmia Rates After Total Joint Arthroplasty
Bonano, J. C., Aratani, A. K., Sambare, T. D., Goodman, S. B., Huddleston, J. I., Maloney, W. J., Burk, D. R., Aaronson, A. J., Finlay, A. K., & Amanatullah, D. F. (2021) · The Journal of Arthroplasty · doi:10.1016/j.arth.2021.05.022 · Cited by 11
Kim, J. E., Choi, Y., Oh, S. W., Kim, M.-G., Jo, S., Cho, W. Y., Ahn, S. Y., Kwon, Y., & Ko, G.-J. (2022) · Frontiers in Nephrology · doi:10.3389/fneph.2021.821585 · Cited by 12
Chua, H.-E., Zhao, Q., Bhowmick, S. S., Dewey, C. F., Tucker‐Kellogg, L., & Yu, H. (2011) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2147805.2147836 · Cited by 11
Statin-induced liver and muscle toxicities
Lee, W. S., & Kim, J. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-019-0002-3 · Cited by 10
Toroghi, M. K., Cluett, W. R., & Mahadevan, R. (2019) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2019.06.032 · Cited by 11
High-Density Lipoproteins and Acute Kidney Injury
Smith, L. E. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.01.013 · Cited by 12
Zhgun, A. A., Nuraeva, G. K., & Volkov, I. A. (2020) · Applied Sciences · doi:10.3390/app10228290 · Cited by 11
Srisawasdi, P., Rodcharoen, P., Vanavanan, S., Chittamma, A., Sukasem, C., Nakorn, C. N., Dejthevaporn, C., & Kroll, M. H. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s278671 · Cited by 13
Alhakamy, N. A., Badr-Eldin, S. M., Aldawsari, H. M., Alfarsi, A., Neamatallah, T., Okbazghi, S. Z., Fahmy, U. A., Ahmad, O. A. A., Eid, B. G., Mahdi, W. A., et al. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02021-x · Cited by 11
RetractedTherapeutic effect of statins on airway remodeling during asthma
Alabed, M., Elemam, N. M., Ramakrishnan, R. K., Sharif‐Askari, N. S., Kashour, T., Hamid, Q. A., & Halwani, R. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1987890 · Cited by 12
Dosage Forms - Innovation and Future Perspectives
Ahmad, U. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.95734 · Cited by 11
Som, R., Morris, P. J., & Knight, S. R. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2543-x · Cited by 11
Ayothiraman, S. (2011) · The Open Enzyme Inhibition Journal · doi:10.2174/1874940201104010023 · Cited by 11
Ma, H., Liu, Y. H., Xie, H., Zhang, G., Zhan, H., Liu, Z., Wang, P., Geng, Q., & Guo, L. (2017) · Medicine · doi:10.1097/md.0000000000007351 · Cited by 11
Azeem, M., Saleem, Y., Hussain, Z., Zahoor, S., & Javed, M. M. (2018) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-018-1807-4 · Cited by 12
PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant rats
Amput, P., Palee, S., Arunsak, B., Pratchayasakul, W., Kerdphoo, S., Jaiwongkam, T., Chattipakorn, S. C., & Chattipakorn, N. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173347 · Cited by 11
Argani, H., Ghorbani, A., ., N. R., & Rahbani-Nobar, M. (2004) · Lipids in Health and Disease · doi:10.1186/1476-511x-3-6 · Cited by 11
Natural Product-Derived Drugs: Structural Insights into Their Biological Mechanisms
Choi, Y., Kim, Y., Boo, H. J., Yoon, D., Cha, J. S., & Yoo, J. (2025) · Biomolecules · doi:10.3390/biom15091303 · Cited by 13
Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults
Zoungas, S., Wolfe, R. S., Moran, C., Nicholls, S. J., CLOUD, G. C., Reid, C. M., Τonkin, A. M., Beilin, L., Wierzbicki, A. S., Chong, T. T.-J., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2607314 · Cited by 13
Gharehbeglou, M., Yazdani, S., White, K., Haeri, M. R., & Masoumzadeh, N. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/3443813 · Cited by 10
Kaur, G., Jones, M., Howes, L. G., & Hattingh, L. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.12.006 · Cited by 12
The Questionable Quality Profile of Food Supplements: The Case of Red Yeast Rice Marketed Products
Vitiello, A., Izzo, L., Castaldo, L., d’Angelo, I., Ungaro, F., Miro, A., Ritieni, A., & Quaglia, F. (2023) · Foods · doi:10.3390/foods12112142 · Cited by 10
Effect of berberine on pharmacokinetics and pharmacodynamics of atorvastatin in hyperlipidemia rats
Wu, F., Cui, M., Wang, S., Yu, C., Yin, W., Li, J., & Yan, X. (2023) · Xenobiotica · doi:10.1080/00498254.2023.2290648 · Cited by 10
Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9
Barreto, P. S. D., Farinha, C., Coimbra, R., Cachulo, M. L., Melo, J. B., Lechanteur, Y. T. E., Hoyng, C. B., Cunha-Vaz, J. G., & da Silva, R. M. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.6.38 · Cited by 11
Khongwichit, S., Nualla‐ong, A., Prompat, N., Amatatongchai, M., Lieberzeit, P. A., & Chunta, S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108994 · Cited by 10
Exploring novel green synthetic pathways and recent advances in pyrrole and its derivatives
Kaur, R., Sharma, P., Lata, S., Bharwal, A., & Abbot, V. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118295 · Cited by 10
New and Future Parenteral Therapies for the Management of Lipid Disorders
García, R. R., & Burkle, J. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.01.001 · Cited by 10
Nirmala, N., Avendano, E. E., & Morin, R. A. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1982140 · Cited by 10
Becchetti, C., Dirchwolf, M., Schropp, J., Magini, G. M., Müllhaupt, B., Immer, F. F., Dufour, J., Banz, V. M., Berzigotti, A., & Bosch, J. (2022) · Journal of Hepatology · doi:10.1016/s0168-8278(22)01873-6 · Cited by 10
Preventive Therapies in Peripheral Arterial Disease
Shah, A. J., Pavlatos, N., & Kalra, D. K. (2023) · Biomedicines · doi:10.3390/biomedicines11123157 · Cited by 12
Engell, A. E., Jørgensen, H. L., Lind, B., Pottegård, A., Andersen, C. L., Andersen, J. S., Kriegbaum, M., Grand, M. K., & Bathum, L. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01579-6 · Cited by 10
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms
Petry, N., Baye, J. F., Frear, S., Jacobsen, K., Massmann, A., Schultz, A., Heukelom, J. V., & Christensen, K. D. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0055 · Cited by 10
Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions
de Boer, L. M., Wiegman, A., Swerdlow, D. I., Kastelein, J. J. P., & Hutten, B. A. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2118522 · Cited by 10
Regan-Smith, S., Fritzen, R., Hierons, S. J., Ajjan, R., Blindauer, C. A., & Stewart, A. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810302 · Cited by 9
Reduktive Dehydroxylierung von Allylalkoholen durch IspH‐Protein
Gräwert, T., Span, I., Bacher, A., & Groll, M. (2010) · Angewandte Chemie · doi:10.1002/ange.201000833 · Cited by 10
Nimgulkar, C. C., Ghosh, S., Sankar, A. B., Uday, K. P., Surekha, M. V., Madhusudhanachary, P., Annapurna, B. R., Raghu, P., & Bharatraj, D. K. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.02.014 · Cited by 10
Salem, M. M., Maragkos, G. Α., Enríquez-Marulanda, A., Ascanio, L. C., Ravindran, K., Alturki, A. Y., Ogilvy, C. S., Thomas, A. J., & Moore, J. M. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.08.119 · Cited by 10
Duddu, S., Katakia, Y. T., Chakrabarti, R., Sharma, P., & Shukla, P. C. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100699 · Cited by 9
Iacono, G., Abay, A., Gallego‐Murillo, J. S., Aglialoro, F., Yağcı, N., Varga, E., Bijlsma, T., Sohler, J., Fu, K., Reisz, J. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-81746-8 · Cited by 11
Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities
Askarizadeh, F., Karav, S., Jamialahmadi, T., & Sahebkar, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00678-2 · Cited by 9
Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy
Prabhu, N., Kapur, N., Catàlona, W. J., Goldman-Leikin, R. E., Helenowski, I., Jovanovic, B. D., Gurley, M. J., Okwuosa, T. M., & Kuzel, T. M. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.09.027 · Cited by 10
Statin Use Is Associated With a Lower Risk of Blepharitis: A Population-Based Study
Feng, K. M., Chung, C., Chen, Y., Chien, W., & Chien, K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.820119 · Cited by 9
A New Modality in Dyslipidemia Treatment: Antisense Oligonucleotide Therapy
Kim, K., & Choi, S. H. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.3.250 · Cited by 11
Statins for Smith-Lemli-Opitz syndrome
Ballout, R. A., Livinski, A. A., Fu, Y., Steiner, R. D., & Remaley, A. T. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013521.pub2 · Cited by 9
Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population
Alqasrawi, M. N., Al-Mahayri, Z. N., Alblooshi, H., AlSafar, H. S., & Ali, B. R. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611283841231227064343 · Cited by 9
Lee, K.-J., Lee, Y.-M., Yang, S.-B., Lee, J. H., Kim, H. R., Lim, J.-H., & Park, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.008 · Cited by 10
Zaid, A. N., Assali, M., Zalmout, S., & Basheer, A. (2016) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2016-000913 · Cited by 9
Shivani, Y., Yadav, S., Sasikala, C., & Ramana, C. V. (2017) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.002224 · Cited by 9
A Brief Drug Class Review: Considerations for Statin Use, Toxicity, and Drug Interactions
Wooten, J. M. (2018) · Southern Medical Journal · doi:10.14423/smj.0000000000000752 · Cited by 9
Chao, T., Hsiao, P., Liu, M.-E., Wu, C.-J., Chiang, F., Chen, Z., Chen, C.-P., Yeh, H., Lee, T.-H., & Chiang, C. (2019) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000062 · Cited by 7
Cui, M., Zhu, F., Yin, Y., Sui, Y., Yan, X., & Chen, T. (2021) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-021-00738-5 · Cited by 9
Ben-Naim, L., Khalaila, I., & Papo, N. (2021) · Protein Engineering Design and Selection · doi:10.1093/protein/gzab032 · Cited by 9
David, M. A., Reiter, A. J., Dunham, C. L., Castile, R. M., Abraham, J., Iannucci, L. E., Shah, I. D., Havlioglu, N., Chamberlain, A. M., & Lake, S. P. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.803403 · Cited by 9
Elmowafy, E. M., Pavoni, L., Perinelli, D. R., Tiboni, M., Casettari, L., Cespi, M., El‐Khouly, A., Soliman, M. E., & Bonacucina, G. (2022) · European Food Research and Technology · doi:10.1007/s00217-022-04105-9 · Cited by 9
Jayanna, M. B., & Robinson, J. G. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13701 · Cited by 9
Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens
Falvo, P., Orecchioni, S., Roma, S., Raveane, A., & Bertolini, F. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200817104912 · Cited by 9
Jhaveri, A., Sibley, R. A., Spatz, E. S., & Dodson, J. A. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01499-y · Cited by 10
Statins in Graves Orbitopathy: A New Therapeutic Tool
Lanzolla, G., Comi, S., Cosentino, G., Pakdel, F., & Marinò, M. (2023) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000002525 · Cited by 8
Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future
Faluk, M. A., Wardhere, A., Mohamoud, A. A., Nor, M. A., Bampastsias, D., Oikonomou, E., Almubaid, Z., & Hemyari, B. A. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102637 · Cited by 8
Gul, U., Aung, T., Martin, M., Farrukh, D. N., Shah, P., Lovely, Z. S., León, E. M., Alansaari, M., Maini, S., Fariduddin, M. M., et al. (2024) · Cureus · doi:10.7759/cureus.76519 · Cited by 10
Pharmacogenomics and its Role in Cardiovascular Diseases: A Narrative Literature Review
Kayani, M., Sangeetha, G. K., Sarangi, S., G, L., Sharma, S., Adedara, V. O., Abdallah, S., Katz, K., Mora, G. R., Kommuru, S., et al. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x334668241227074314 · Cited by 9
Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation
Sgarra, L., Desantis, V., Matteucci, A., Caccavo, V. P., Troisi, F., Monaco, A. D., Mangini, F., Katsouras, G., Guaricci, A. I., Dadamo, M. L., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13030660 · Cited by 9
Oriakhi, K., & Uadia, P. O. (2020) · Planta Medica International Open · doi:10.1055/a-1323-0786 · Cited by 8
Sweidan, K., Sheikha, G. M. A., Shattat, G. F., Al‐Qirim, T. M., & Bkhaitan, M. M. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e191142 · Cited by 8
Integrated systems biology approach identifies gene targets for endothelial dysfunction
Pinheiro‐de‐Sousa, I., Fonseca‐Alaniz, M. H., Giudice, G., Valadão, I. C., Modestia, S. M., Viana-Mattioli, S., la Rosa, R. D., Zalmas, L., Fang, Y. H., Petsalaki, E., et al. (2023) · Molecular Systems Biology · doi:10.15252/msb.202211462 · Cited by 7
Trentini, A., Manfrinato, M. C., Bellini, T., Volta, C. A., Hanau, S., Corte, F. D., Cervellati, C., Rosta, V., & Spadaro, S. (2018) · Biochemia Medica · doi:10.11613/bm.2019.010703 · Cited by 8
Mesenchymal subtype neuroblastomas are addicted to TGF-βR2/HMGCR-driven protein geranylgeranylation
Stokes, M. E., Small, J. C., Vasciaveo, A., Shimada, K., Hirschhorn, T., Califano, A., & Stockwell, B. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-67310-0 · Cited by 8
Development of One Pot Strategy for Hyper Production and In Vivo Evaluation of Lovastatin
Azeem, M., Arshad, M. I., Mahmood, S., Abrar, S., Zahoor, A. F., Javed, S., Tariq, B., & Hayyat, K. (2020) · Molecules · doi:10.3390/molecules25194380 · Cited by 8
Harding, I. H., Ryan, J. L., Heritier, S. R., Spark, S., Flanagan, Z., McIntyre, R., Anderson, C. S., Naismith, S. L., Chong, T. T. ‐., O'Sullivan, M. J., et al. (2023) · BMJ Neurology Open · doi:10.1136/bmjno-2023-000541 · Cited by 9
Understanding the controversial drug targets in epilepsy and pharmacoresistant epilepsy
Lalitha, S., Minz, R. W., & Medhi, B. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0043 · Cited by 8
Shahlaei, M., Zamani, P., Farhadian, N., Balaei, F., Ansari, M., & Moradi, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.095 · Cited by 8
El-Haibi, C., Rahal, E., Khauli, R. B., & Abdelnoor, A. M. (2006) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970600928056 · Cited by 7
Chen, K., Chen, Y., & Huang, H. (2024) · Drugs in R&D · doi:10.1007/s40268-024-00474-6 · Cited by 8
Liu, Y., Chen, J., Yuan, Y., Niu, P., Wu, M., Shang, B., Lu, W., Zou, X., & Yao, G. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1520107 · Cited by 7
Wang, L., Hui, X., Huang, R., & Xiao, Y. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.03.017 · Cited by 7
Attia, K. A. M., Abdel‐Monem, A. H., Abdel‐Raoof, A. M., & Eissa, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-94907-0 · Cited by 7
Arendt, N., Kopsida, M., Lennernäs, H., Sjöblom, M., & Heindryckx, F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178282 · Cited by 8
Mehta, A., Dixon, D. L., Saeed, A., Kelly, M. S., Gulati, M., Shapiro, M. D., Sperling, L. S., & Virani, S. S. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01861-2 · Cited by 7
Mohamed, A. A. M., & Ray, K. K. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001074 · Cited by 7
Drug screen identifies verteporfin as a regulator of lipid metabolism in macrophage foam cells
Hoeffner, N., Paul, A., & Goo, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-46467-4 · Cited by 8
The impact of statin use on short-term and long-term mortality in patients with heart failure
Zheng, X., Tan, L., & Zhang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1397763 · Cited by 7
Atta, M. (2015) · Advances in Alzheimer s Disease · doi:10.4236/aad.2015.41002 · Cited by 7
Bioprospecting of Lovastatin Producing Fungi Isolated from Soil Samples
Chaynika, P., & Shivakumar, S. (2014) · Cited by 7
THE PROSPECT, PROMISES AND HINDRANCES OF STATIN BASE MOLECULES: LOOK BACK TO LOOK FORWARD
Affandi, M. M. R. M. M., Tripathy, M., & Majeed, A. B. A. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 7
Sabeel, S., Motaung, B., Ozturk, M., Mukasa, S. L., Kengne, A. P., Blom, D. J., Sliwa, K. S., Nepolo, E., Günther, G., Wilkinson, R. J., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039034 · Cited by 7
Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production
Taruselli, M. T., Kolawole, E. M., Qayum, A. A., Haque, T. T., Caslin, H. L., Abebayehu, D., Kee, S. A., Dailey, J. M., Jackson, K. G., Burchett, J. R., et al. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104457 · Cited by 8
The Link Between Statins and Breast Cancer in Mouse Models: A Systematic Review
Watson, R., Tulk, A., & Erdrich, J. (2022) · Cureus · doi:10.7759/cureus.31893 · Cited by 7
Wang, A., Lin, G., Keller, J. J., & Wang, L. (2023) · Journal of Periodontology · doi:10.1002/jper.23-0166 · Cited by 7
Mamun, A. A., Hashimoto, M., Katakura, M., Tanabe, Y., Tsuchikura, S., Hossain, S., & Shido, O. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.038 · Cited by 7
Ahn, Y., Gebereamanuel, M. R., Oh, E. K., & Kwon, O. (2017) · Journal of Nutrition and Health · doi:10.4163/jnh.2017.50.3.225 · Cited by 7
Metadata
- Authors
- Stancu, C., & Sima, A.
- Affiliations
- Romanian Academy (RO)
- Corresponding author
- Sima, Anca
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 5
- Issue
- 4
- Pages
- 378-387
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- PMC
- PMC6740083
- OpenAlex
- W2006572302
- Cited by
- 911
- References
- 42
- Citations by year
- 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cellular and Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
- MeSH terms
- Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review